Intended Use:
DefineMBC is a test designed for use on breast cancer patients when metastatic disease is suspected or has previously been confirmed and for whom surgical tissue biopsy is not feasible, or when the results of surgical biopsy are indeterminate or inadequate including when there is insufficient tissue sample to process.
Epic Sciences is licensed under the Clinical Laboratory Improvement Amendment of 1988 (CLIA) and is authorized to provide diagnostic services.
"DefineMBC" is a trademark of Epic Sciences, Inc.; and "The Power of Clarity" and the stylized "e" are trademarks of Epic Sciences, Inc. registered in the United States.
©2022 Epic Sciences
